CD30 CAR-T cells not only target CD30+ embryonal carcinoma (EC) cells through CAR-T cells but also eliminate surrounding CD30-ECs through Fas/FasL interactions. The gene discussed is TNFRSF8; the disease is embryonal carcinoma.